The V2 System is an over-the-wire, balloon catheter with electrodes and thermistors mounted on the exterior of the balloon and by using RF balloon catheter technology it delivers RF energy with in 30 seconds per artery.
Vessix said rapid RF treatment time increases the efficiency of the procedure, reduces discomfort for the patient with less exposure to radiation, lower amount of contrast dye and, therefore, lower renal toxicity to the patient.
The company will begin its first-in-man clinical study in February 2012.
Vessix Vascular will unveil the device at LINC 2012 in Leipzig, Germany on 26 January 2012.
